Eric Faulkner, Senior Director of US Market Access and Reimbursement, will participate in a workshop at the 14th International Society for Cellular Therapy (ISCT) Annual Meeting. The meeting will be held May 17-21 at the Miami Convention Center and Mr. Faulkner’s workshop will be held from 3:30 to 5:00 on Sunday, May 18th and is titled Financing for Cell Therapy Companies.

Mr. Faulkner’s responsibilities at RTI Health Solutions involve evaluation of US and international pricing and reimbursement issues, health technology assessment practices, product reimbursement and commercialization strategies and changing health policy. He has recently served as an expert advisor to the Personalized Medicine Subcommittee of the President’s Council of Advisors on Science and Technology and serves on the Leadership Committee of the Health Technology Assessment for Emerging Technologies Working Group of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR).

In addition to his role at RTI Health Solutions, Mr. Faulkner also serves as Director of the Genomic Biotech Institute (GBI) of the National Association of Managed Care Physicians (NAMCP) and is Editor-in-Chief of the GBI special section of the Journal of Managed Care Medicine, Genomics and Biotechnology.

Additional information about the conference is available here.

Please contact Eric directly if you plan to attend the conference and would like to pre-arrange a meeting time with him.